Viewing StudyNCT00082862



Ignite Creation Date: 2024-05-05 @ 11:35 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00082862
Status: UNKNOWN
Last Update Posted: 2012-02-13
First Post: 2004-05-14

Brief Title: Cisplatin Metronomic Low-Dose Interferon Alfa Gemcitabine and Fever-Range Whole-Body Hyperthermia in Treating Patients With Inoperable or Metastatic Pancreatic Cancer
Sponsor: The University of Texas Health Science Center Houston
Organization: National Cancer Institute NCI

Conditions & Keywords Data

Conditions:
Name
Pancreatic Cancer
Keywords:
Name View
stage II pancreatic cancer View
stage III pancreatic cancer View
recurrent pancreatic cancer View
stage IV pancreatic cancer View